The prognostic stratification of patients with Idiopathic Dilated Cardiomyopathy (iDCM) is a difficult task. Here, we assessed the additive value of the evaluation of biomarkers of inflammasome activation and systemic inflammation for the long-term risk stratification of iDCM patients
18siAim: Contemporary survival trends in dilated cardiomyopathy (DCM) are largely unknown. The aim o...
Dilated cardiomyopathy (DCM) represents the most common cardiomyopathy worldwide. The familial type...
BACKGROUND: Few data are available in the literature regarding the characteristics and prognosis of ...
AIMS: The prognostic stratification of patients with Idiopathic Dilated Cardiomyopathy (iDCM) is a d...
Inflammation-related biomarkers are associated with clinical outcomes in mixed-etiology chronic hear...
Inflammation-related biomarkers are associated with clinical outcomes in mixed-etiology chronic hear...
Our purpose in this study was to investigate the correlation of clinical, electrocardiographic, hemo...
ACE-inhibitors, \u3b2-blockers, implantable cardioverter-defibrillator (ICD) and cardiac resynchroni...
BACKGROUND: Dilated cardiomyopathy (DCM) is a final common manifestation of heterogenous etiologies....
Background: Inflammatory dilated cardiomyopathy (iDCM) is a common debilitating disease with poor pr...
Background: Dilated Cardiomyopathy (DCM) is the most common functional type of cardiomyopathy in chi...
Background Dilated cardiomyopathy (DCM) has a 20% 5 year mortality. Cardiac MR (CMR) is an establish...
23siBACKGROUND: Dilated cardiomyopathy is associated with increased risk of major cardiovascular eve...
Objectives: To investigate whether an inflammatory marker of neutrophil to lymphocyte ratio (NLR) pr...
Aims To determine the prognostic value of multilevel assessment of fibrosis in dilated cardiomyopath...
18siAim: Contemporary survival trends in dilated cardiomyopathy (DCM) are largely unknown. The aim o...
Dilated cardiomyopathy (DCM) represents the most common cardiomyopathy worldwide. The familial type...
BACKGROUND: Few data are available in the literature regarding the characteristics and prognosis of ...
AIMS: The prognostic stratification of patients with Idiopathic Dilated Cardiomyopathy (iDCM) is a d...
Inflammation-related biomarkers are associated with clinical outcomes in mixed-etiology chronic hear...
Inflammation-related biomarkers are associated with clinical outcomes in mixed-etiology chronic hear...
Our purpose in this study was to investigate the correlation of clinical, electrocardiographic, hemo...
ACE-inhibitors, \u3b2-blockers, implantable cardioverter-defibrillator (ICD) and cardiac resynchroni...
BACKGROUND: Dilated cardiomyopathy (DCM) is a final common manifestation of heterogenous etiologies....
Background: Inflammatory dilated cardiomyopathy (iDCM) is a common debilitating disease with poor pr...
Background: Dilated Cardiomyopathy (DCM) is the most common functional type of cardiomyopathy in chi...
Background Dilated cardiomyopathy (DCM) has a 20% 5 year mortality. Cardiac MR (CMR) is an establish...
23siBACKGROUND: Dilated cardiomyopathy is associated with increased risk of major cardiovascular eve...
Objectives: To investigate whether an inflammatory marker of neutrophil to lymphocyte ratio (NLR) pr...
Aims To determine the prognostic value of multilevel assessment of fibrosis in dilated cardiomyopath...
18siAim: Contemporary survival trends in dilated cardiomyopathy (DCM) are largely unknown. The aim o...
Dilated cardiomyopathy (DCM) represents the most common cardiomyopathy worldwide. The familial type...
BACKGROUND: Few data are available in the literature regarding the characteristics and prognosis of ...